We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Diagnos Inc | TSXV:ADK | TSX Venture | Common Stock |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.015 | -4.55% | 0.315 | 0.315 | 0.33 | 0.33 | 0.315 | 0.33 | 65,100 | 20:59:58 |
From Jul 2021 to Jul 2024
BTV’s CEO Clips, a series of short video profiles on innovative publicly traded companies across North America, will feature DIAGNOS on the BNN Bloomberg Channel beginning September 25th, Saturday & Sunday, throughout the day and evenings. View link: https://b-tv.com/diagnos-using-ai-to-analyze-the-retina/
Further online distribution through BTV’s CEO Clips includes: Thomson Reuters Terminals, Yahoo Finance, Stockwatch, Bloomberg, Stockhouse.com and BTV’s YouTube channel.
About the BNN Bloomberg Channel and BTV:BNN Bloomberg is Canada’s only Business News Network reporting on finance and the markets.
BTV-Business Television and CEO Clips produce and create the largest library of issuer videos and campaigns for broadcast on TV and financial sites.
About DIAGNOSDIAGNOS is a publicly traded Canadian corporation dedicated to early detection of critical health problems based on its FLAIRE Artificial Intelligence (AI) platform. FLAIRE allows for quick modifying and developing of applications such as CARA (Computer Assisted Retina Analysis). CARA’s image enhancement algorithms provide sharper, clearer and easier-to-analyze retinal images. CARA is a cost-effective tool for real-time screening of large volumes of patients. CARA has been cleared for commercialization by the following regulators: Health Canada, the FDA (USA), CE (Europe), COFEPRIS (Mexico) and Saudi FDA (Saudi Arabia).
Additional information is available at www.diagnos.com and www.sedar.com.
For further information, please contact:
This press release contains forward-looking information. We cannot guarantee that the forward-looking information mentioned will prove to be accurate, as there may be a significant discrepancy between actual results or future events and those mentioned in this statement. DIAGNOS disclaims any intention or obligation to publicly update or revise any forward-looking information, whether as a result of new information, future events or otherwise. The forward-looking information contained in this press release is expressly covered by this caution.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Contact: info@b-tv.com Mr. André Larente, President DIAGNOS Inc. Tel: 450-678-8882 ext. 224 alarente@diagnos.ca Corporate Communications: Nancy Massicotte IR Pro Communications Inc. Dir: +1 604-507-3377 TF: 1-866-503-3377 Email: nancy@irprocommunications.com
1 Year Diagnos Chart |
1 Month Diagnos Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
